Documents
Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 100MG | 0 | PACLITAXEL | PACLITAXEL |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | TA | 2022-07-15 | STANDARD |
Submissions Property Types
CDER Filings
TEVA PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 216338
[companyName] => TEVA PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"PACLITAXEL","activeIngredients":"PACLITAXEL","strength":"100MG","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"07\/15\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"Type 5 - New Formulation or New Manufacturer","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2022\\\/216338Orig1s000TAltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-07-15
)
)